Medical Information Only. Always consult your healthcare provider before enrolling in any clinical trial.
NCT01959464 · ClinicalTrials.gov registry record · Phase 4
Sexual Absorption of Vaginal Progesterone
A Phase 4 study, sponsored by Wake Forest University Health Sciences.
- Completed
- Registry status
- Phase 4
- Development phase
- 20
- Enrollment target
NCT01959464 is a Phase 4 study that has completed, run by Wake Forest University Health Sciences. The registered enrollment target is 20 participants.
The verdict
NCT01959464, a Phase 4 study, has completed, sponsored by Wake Forest University Health Sciences.
- COMPLETED
- Registry status
- Phase 4
- Development phase
- 20 participants
- Enrollment target
Study Summary
The purpose of this study is to determine if sexual intercourse lowers serum progesterone in women using vaginal progesterone gel (Crinone®), and increases serum progesterone in their male sexual partners. We hypothesize, based on previous estrogen studies done by our group, that intercourse will interfere with absorption of vaginal progesterone.
Interventions
- DRUG Crinone vaginal progesterone gel
- DRUG Placebo vaginal gel
Trial Details
| Field | Value |
|---|---|
| Enrollment Target | 20 participants |
| Start Date | 2008-11 |
| Est. Completion | 2010-09 |
| Phase | Phase 4 |
Interested in This Trial?
Full Details on ClinicalTrials.gov ↗What the Registry Record Tells You About NCT01959464
The ClinicalTrials.gov registry entry for NCT01959464 describes a study currently listed as completed, categorized as Phase 4. The registered enrollment target is 20 participants, a figure that helps gauge the scale of data the investigators plan to collect. The listed sponsor is Wake Forest University Health Sciences, which has 1,140 total studies on file at ClinicalTrials.gov.
The record links to 0 conditions, and to 2 interventions - of which Crinone vaginal progesterone gel is the first listed.
NCT01959464 reports 0 study locations.
Frequently Asked Questions
What is clinical trial NCT01959464 about?
NCT01959464 is a clinical study titled "Sexual Absorption of Vaginal Progesterone". The purpose of this study is to determine if sexual intercourse lowers serum progesterone in women using vaginal progesterone gel (Crinone®), and increases serum progesterone in their male sexual partners. We hypothesize, based on previous estrogen studies done by our group, that intercourse will in...
What is the current status of trial NCT01959464?
This trial is currently completed. It is a Phase 4 study. The enrollment target is 20 participants. The study started on 2008-11. Estimated completion is 2010-09.
What interventions are being tested in trial NCT01959464?
The interventions under investigation include: Crinone vaginal progesterone gel (DRUG), Placebo vaginal gel (DRUG).
Who is sponsoring clinical trial NCT01959464?
This trial is sponsored by Wake Forest University Health Sciences, which has 1,140 total clinical trials registered on ClinicalTrials.gov.
Learn More About Clinical Trials
Explore more on PlainTrial
Read our methodology - how this data is sourced, computed, and verified.
Related
Every figure on PlainTrial is rendered directly from the ClinicalTrials.gov registry, no number is typed in by an editor. This page mirrors this trial's own ClinicalTrials.gov registry record, live from the dataset. See our editorial standards & corrections policy, the methodology behind these numbers, or report a data error.